Search This Blog
With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
Posts
Showing posts from November, 2017
PROMISing answers for our intermediate risk Oncotypes.
- Get link
- Other Apps
Another adjuvant Avastin letdown.
- Get link
- Other Apps
Roy Moore, Louis CK and Tamoxifen.
- Get link
- Other Apps
Pembro promises Merck-y results in sarcoma.
- Get link
- Other Apps
I just wanna know where da GOLD at.
- Get link
- Other Apps
MARCHing to the beat of the same old drum.
- Get link
- Other Apps